glp 1 rezeptoragonisten Inkretinmimetika (GLP-1-Rezeptoragonisten) in Pharmacology Millionen Frauen. Eine Dosis. Kein

Transcriptional regulatory factor X6 (Rfx6) increases gastric inhibitory polypeptide (GIP) expression in enteroendocrine K-cells and is involved in GIP hypersecretion in high fat diet-induced obesity

A recent study suggests that patients taking Ozempic and Wegovy may face an elevated risk of developing non-arteritic anterior ischemic optic neuropathy (NAION), a rare condition causing sudden vision loss

Opportunity Analysis of GLP-1 Nutritional Support Market in Germany The CAGR in Germany increased from around 9.1% in 2020 to 2024 to 12.7% during 2025 to 2035, driven by higher institutional procurement of GLP-1-specific nutrition products for diabetes and obesity support

[DOI] [PMC free article] [PubMed] [Google Scholar] 80.Wang W, Volkow ND, Berger NA, Davis PB, Kaelber DC, Xu R

Onakpoya, I., Hung, S

Touch-up treatments maintain these effects over time